Browse by Research Area

Bader, Michael

Selectivity and safety characterization of a xanthine-imidazothiazole lead structure: a novel tryptophan hydroxylase inhibitor of peripheral serotonin synthesis.
Wesolowski, R., Schütz, A., Lisurek, M., Nazaré, M., Heinemann, U., Pleimes, D., Bader, M. and Specker, E.
ACS Pharmacology & Translational Science 8 (6): 1678-1693. 13 June 2025

Blankenstein, Thomas

Mice with a diverse human T cell receptor repertoire selected on multiple HLA class I molecules.
Dhamodaran, A., Chen, X., Fellmer, N., Agrawal, D., Danner, E., Kühn, R. and Blankenstein, T.
Nature Communications 16 (1): 5432. 1 July 2025

Heinemann, Udo

Selectivity and safety characterization of a xanthine-imidazothiazole lead structure: a novel tryptophan hydroxylase inhibitor of peripheral serotonin synthesis.
Wesolowski, R., Schütz, A., Lisurek, M., Nazaré, M., Heinemann, U., Pleimes, D., Bader, M. and Specker, E.
ACS Pharmacology & Translational Science 8 (6): 1678-1693. 13 June 2025

Kettritz, Ralph (ECRC)

CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Jerke, U., Eulenberg-Gustavus, C., Wagner, D.L., Schreiber, A. and Kettritz, R.
Kidney International 108 (1): 145-149. July 2025

Kuehn, Ralf (MDC/BIH)

Mice with a diverse human T cell receptor repertoire selected on multiple HLA class I molecules.
Dhamodaran, A., Chen, X., Fellmer, N., Agrawal, D., Danner, E., Kühn, R. and Blankenstein, T.
Nature Communications 16 (1): 5432. 1 July 2025

Schreiber, Adrian (ECRC)

CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Jerke, U., Eulenberg-Gustavus, C., Wagner, D.L., Schreiber, A. and Kettritz, R.
Kidney International 108 (1): 145-149. July 2025

Schuetz, Anja

Selectivity and safety characterization of a xanthine-imidazothiazole lead structure: a novel tryptophan hydroxylase inhibitor of peripheral serotonin synthesis.
Wesolowski, R., Schütz, A., Lisurek, M., Nazaré, M., Heinemann, U., Pleimes, D., Bader, M. and Specker, E.
ACS Pharmacology & Translational Science 8 (6): 1678-1693. 13 June 2025

Von Kries, Jens Peter / Nazaré, Marc

Selectivity and safety characterization of a xanthine-imidazothiazole lead structure: a novel tryptophan hydroxylase inhibitor of peripheral serotonin synthesis.
Wesolowski, R., Schütz, A., Lisurek, M., Nazaré, M., Heinemann, U., Pleimes, D., Bader, M. and Specker, E.
ACS Pharmacology & Translational Science 8 (6): 1678-1693. 13 June 2025